We read the article ''Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia'' by Turan et al 1 with interest. They assessed the potential association of serum endocan level with coronary artery ectasia (CAE). They demonstrated that a high endocan level reflects the presence and severity of isolated CAE.
Coronary artery ectasia is an abnormality of the coronary anatomy and has been characterized as localized or diffused nonobstructive lesion of the epicardial coronary arteries, by the enlargement of diameter at least 1.5 times greater than the diameter of the normal portion of the artery. 2 Endocan (endothelial cell-specific molecule 1) is a marker of vascular pathology and a mediator of inflammation associated with cardiovascular disease (CVD). 3, 4 Furthermore, in the study connected by Balta et al 4 , endocan levels related better to CVD, that is also an additional evidence of a relationship between endocan and endothelial dysfunction. However, the studies by Syed et al 5 and Icli et al 6 reported that endocan levels may predict systemic diseases, so the conclusion is that endocan is a systemic inflammation marker. However, in the limitation section of Turan et al 1 article they said ''we did not measure a systemic inflammatory marker.'' 1 In the Turan et al 1 study, they also compared endocan levels and neutrophil-tolymphocyte ratio as systemic inflammatory marker. To our knowledge, in these trials related with inflammatory markers, a novel marker should compare with high-sensitivity Creactive protein (CRP) before others, because it is synthesized in response to factors released by macrophages and it is the most useful marker for systemic inflammation. 7 So, Turan et al 1 study did not mention the combinations of these inflammatory biomarkers with CRP. Besides, in many studies like these, endocan was compared with CRP. [3] [4] [5] [6] 8, 9 The Turan et al 1 study may be the first to report the relationship between endocan and CAE, but if they analyzed CRP levels of patients with CAE, it may be clearer whether increased endocan levels are related to CAE or systemic inflammation.
